VH3-87774-41054
4 vaccinations
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 852 / AZ
- Registered
- 2022-10-19
- Relationship
- Adult relative or friend
- Guardian
- 3SQ-13860-81464
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-14
Dose 1 — Janssen/Johnson & Johnson
-
2021-10-30
Dose 2 — Pfizer-BioNTech
-
2022-04-23
Dose 3 — Pfizer-BioNTech
-
2022-10-01
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-19
Registered in v-safe
-
2022-10-19
Survey response — day 14, dose 4, dependentMedDRA: Cough, Headache, Nasal congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache, nasal congestion, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-10-29
- 2022-11-07
- 2022-11-16
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-14 | Janssen/Johnson & Johnson | No |
| 2 | 2021-10-30 | Pfizer-BioNTech | No |
| 3 | 2022-04-23 | Pfizer-BioNTech | No |
| 4 | 2022-10-01 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 14, dose 4, dependent
Symptoms: Headache, nasal congestion, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release